NCT03859388View on ClinicalTrials.gov

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Active, not recruitingOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Rejection Chronic RenalKidney Transplant Rejection

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors

lead

Cedars-Sinai Medical Center

OTHER